Global Toxoplasma Gondii Recombinant Antigen Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Toxoplasma Gondii Recombinant Antigen market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Toxoplasma Gondii Recombinant Antigen is a protein produced by genetic engineering technology that mimics the natural antigen of Toxoplasma gondii. Toxoplasma gondii is a parasite that causes toxoplasmosis in humans and animals. Recombinant antigens are used in in vitro diagnostic reagents to detect immune responses caused by Toxoplasma infection, such as the presence of antibodies. By using recombinant antigens, the specificity and sensitivity of diagnosis can be improved and cross-reactions and non-specific reactions can be reduced.
This report is a detailed and comprehensive analysis for global Toxoplasma Gondii Recombinant Antigen market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Global Toxoplasma Gondii Recombinant Antigen market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Toxoplasma Gondii Recombinant Antigen market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Toxoplasma Gondii Recombinant Antigen market shares of main players, in revenue ($ Million), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Chapter 2, to profile the top players of Toxoplasma Gondii Recombinant Antigen, with revenue, gross margin, and global market share of Toxoplasma Gondii Recombinant Antigen from 2021 to 2026.
Chapter 3, the Toxoplasma Gondii Recombinant Antigen competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Toxoplasma Gondii Recombinant Antigen market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Toxoplasma Gondii Recombinant Antigen.
Chapter 13, to describe Toxoplasma Gondii Recombinant Antigen research findings and conclusion.
Toxoplasma Gondii Recombinant Antigen is a protein produced by genetic engineering technology that mimics the natural antigen of Toxoplasma gondii. Toxoplasma gondii is a parasite that causes toxoplasmosis in humans and animals. Recombinant antigens are used in in vitro diagnostic reagents to detect immune responses caused by Toxoplasma infection, such as the presence of antibodies. By using recombinant antigens, the specificity and sensitivity of diagnosis can be improved and cross-reactions and non-specific reactions can be reduced.
This report is a detailed and comprehensive analysis for global Toxoplasma Gondii Recombinant Antigen market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Toxoplasma Gondii Recombinant Antigen market size and forecasts, in consumption value ($ Million), 2021-2032Global Toxoplasma Gondii Recombinant Antigen market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Toxoplasma Gondii Recombinant Antigen market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Toxoplasma Gondii Recombinant Antigen market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Toxoplasma Gondii Recombinant Antigen
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Toxoplasma Gondii Recombinant Antigen market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Full-Length Antigen
- Truncated Antigen
Market segment by Application
- In Vitro Diagnostics
- Vaccine Development
- Others
Market segment by players, this report covers
- Rekom Biotech
- Roche
- Thermal Fisher
- Bio-Rad
- Abcam
- Meridian Bioscience
- Fapon Biotech
- ViroGen Corporation
- Medix Biochemica
- Creative Diagnostics
- Prospec
- Cusabio
- Abbexa
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Toxoplasma Gondii Recombinant Antigen product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top players of Toxoplasma Gondii Recombinant Antigen, with revenue, gross margin, and global market share of Toxoplasma Gondii Recombinant Antigen from 2021 to 2026.
Chapter 3, the Toxoplasma Gondii Recombinant Antigen competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Toxoplasma Gondii Recombinant Antigen market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Toxoplasma Gondii Recombinant Antigen.
Chapter 13, to describe Toxoplasma Gondii Recombinant Antigen research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Toxoplasma Gondii Recombinant Antigen by Type
1.3.1 Overview: Global Toxoplasma Gondii Recombinant Antigen Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type in 2025
1.3.3 Full-Length Antigen
1.3.4 Truncated Antigen
1.4 Global Toxoplasma Gondii Recombinant Antigen Market by Application
1.4.1 Overview: Global Toxoplasma Gondii Recombinant Antigen Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 In Vitro Diagnostics
1.4.3 Vaccine Development
1.4.4 Others
1.5 Global Toxoplasma Gondii Recombinant Antigen Market Size & Forecast
1.6 Global Toxoplasma Gondii Recombinant Antigen Market Size and Forecast by Region
1.6.1 Global Toxoplasma Gondii Recombinant Antigen Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Toxoplasma Gondii Recombinant Antigen Market Size by Region, (2021-2032)
1.6.3 North America Toxoplasma Gondii Recombinant Antigen Market Size and Prospect (2021-2032)
1.6.4 Europe Toxoplasma Gondii Recombinant Antigen Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Toxoplasma Gondii Recombinant Antigen Market Size and Prospect (2021-2032)
1.6.6 South America Toxoplasma Gondii Recombinant Antigen Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Rekom Biotech
2.1.1 Rekom Biotech Details
2.1.2 Rekom Biotech Major Business
2.1.3 Rekom Biotech Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.1.4 Rekom Biotech Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Rekom Biotech Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.2.4 Roche Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Roche Recent Developments and Future Plans
2.3 Thermal Fisher
2.3.1 Thermal Fisher Details
2.3.2 Thermal Fisher Major Business
2.3.3 Thermal Fisher Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.3.4 Thermal Fisher Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Thermal Fisher Recent Developments and Future Plans
2.4 Bio-Rad
2.4.1 Bio-Rad Details
2.4.2 Bio-Rad Major Business
2.4.3 Bio-Rad Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.4.4 Bio-Rad Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bio-Rad Recent Developments and Future Plans
2.5 Abcam
2.5.1 Abcam Details
2.5.2 Abcam Major Business
2.5.3 Abcam Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.5.4 Abcam Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Abcam Recent Developments and Future Plans
2.6 Meridian Bioscience
2.6.1 Meridian Bioscience Details
2.6.2 Meridian Bioscience Major Business
2.6.3 Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.6.4 Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Meridian Bioscience Recent Developments and Future Plans
2.7 Fapon Biotech
2.7.1 Fapon Biotech Details
2.7.2 Fapon Biotech Major Business
2.7.3 Fapon Biotech Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.7.4 Fapon Biotech Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Fapon Biotech Recent Developments and Future Plans
2.8 ViroGen Corporation
2.8.1 ViroGen Corporation Details
2.8.2 ViroGen Corporation Major Business
2.8.3 ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.8.4 ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 ViroGen Corporation Recent Developments and Future Plans
2.9 Medix Biochemica
2.9.1 Medix Biochemica Details
2.9.2 Medix Biochemica Major Business
2.9.3 Medix Biochemica Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.9.4 Medix Biochemica Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Medix Biochemica Recent Developments and Future Plans
2.10 Creative Diagnostics
2.10.1 Creative Diagnostics Details
2.10.2 Creative Diagnostics Major Business
2.10.3 Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.10.4 Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Creative Diagnostics Recent Developments and Future Plans
2.11 Prospec
2.11.1 Prospec Details
2.11.2 Prospec Major Business
2.11.3 Prospec Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.11.4 Prospec Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Prospec Recent Developments and Future Plans
2.12 Cusabio
2.12.1 Cusabio Details
2.12.2 Cusabio Major Business
2.12.3 Cusabio Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.12.4 Cusabio Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Cusabio Recent Developments and Future Plans
2.13 Abbexa
2.13.1 Abbexa Details
2.13.2 Abbexa Major Business
2.13.3 Abbexa Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.13.4 Abbexa Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Abbexa Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Toxoplasma Gondii Recombinant Antigen Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Toxoplasma Gondii Recombinant Antigen by Company Revenue
3.2.2 Top 3 Toxoplasma Gondii Recombinant Antigen Players Market Share in 2025
3.2.3 Top 6 Toxoplasma Gondii Recombinant Antigen Players Market Share in 2025
3.3 Toxoplasma Gondii Recombinant Antigen Market: Overall Company Footprint Analysis
3.3.1 Toxoplasma Gondii Recombinant Antigen Market: Region Footprint
3.3.2 Toxoplasma Gondii Recombinant Antigen Market: Company Product Type Footprint
3.3.3 Toxoplasma Gondii Recombinant Antigen Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Toxoplasma Gondii Recombinant Antigen Consumption Value and Market Share by Type (2021-2026)
4.2 Global Toxoplasma Gondii Recombinant Antigen Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2026)
5.2 Global Toxoplasma Gondii Recombinant Antigen Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2032)
6.2 North America Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2032)
6.3 North America Toxoplasma Gondii Recombinant Antigen Market Size by Country
6.3.1 North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2032)
6.3.2 United States Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
6.3.3 Canada Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
6.3.4 Mexico Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2032)
7.2 Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2032)
7.3 Europe Toxoplasma Gondii Recombinant Antigen Market Size by Country
7.3.1 Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2032)
7.3.2 Germany Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
7.3.3 France Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
7.3.5 Russia Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
7.3.6 Italy Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Toxoplasma Gondii Recombinant Antigen Market Size by Region
8.3.1 Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Region (2021-2032)
8.3.2 China Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8.3.3 Japan Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8.3.4 South Korea Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8.3.5 India Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8.3.7 Australia Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2032)
9.2 South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2032)
9.3 South America Toxoplasma Gondii Recombinant Antigen Market Size by Country
9.3.1 South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2032)
9.3.2 Brazil Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
9.3.3 Argentina Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Country
10.3.1 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2032)
10.3.2 Turkey Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
10.3.4 UAE Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Toxoplasma Gondii Recombinant Antigen Market Drivers
11.2 Toxoplasma Gondii Recombinant Antigen Market Restraints
11.3 Toxoplasma Gondii Recombinant Antigen Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Toxoplasma Gondii Recombinant Antigen Industry Chain
12.2 Toxoplasma Gondii Recombinant Antigen Upstream Analysis
12.3 Toxoplasma Gondii Recombinant Antigen Midstream Analysis
12.4 Toxoplasma Gondii Recombinant Antigen Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Toxoplasma Gondii Recombinant Antigen by Type
1.3.1 Overview: Global Toxoplasma Gondii Recombinant Antigen Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type in 2025
1.3.3 Full-Length Antigen
1.3.4 Truncated Antigen
1.4 Global Toxoplasma Gondii Recombinant Antigen Market by Application
1.4.1 Overview: Global Toxoplasma Gondii Recombinant Antigen Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 In Vitro Diagnostics
1.4.3 Vaccine Development
1.4.4 Others
1.5 Global Toxoplasma Gondii Recombinant Antigen Market Size & Forecast
1.6 Global Toxoplasma Gondii Recombinant Antigen Market Size and Forecast by Region
1.6.1 Global Toxoplasma Gondii Recombinant Antigen Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Toxoplasma Gondii Recombinant Antigen Market Size by Region, (2021-2032)
1.6.3 North America Toxoplasma Gondii Recombinant Antigen Market Size and Prospect (2021-2032)
1.6.4 Europe Toxoplasma Gondii Recombinant Antigen Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Toxoplasma Gondii Recombinant Antigen Market Size and Prospect (2021-2032)
1.6.6 South America Toxoplasma Gondii Recombinant Antigen Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Rekom Biotech
2.1.1 Rekom Biotech Details
2.1.2 Rekom Biotech Major Business
2.1.3 Rekom Biotech Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.1.4 Rekom Biotech Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Rekom Biotech Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.2.4 Roche Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Roche Recent Developments and Future Plans
2.3 Thermal Fisher
2.3.1 Thermal Fisher Details
2.3.2 Thermal Fisher Major Business
2.3.3 Thermal Fisher Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.3.4 Thermal Fisher Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Thermal Fisher Recent Developments and Future Plans
2.4 Bio-Rad
2.4.1 Bio-Rad Details
2.4.2 Bio-Rad Major Business
2.4.3 Bio-Rad Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.4.4 Bio-Rad Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bio-Rad Recent Developments and Future Plans
2.5 Abcam
2.5.1 Abcam Details
2.5.2 Abcam Major Business
2.5.3 Abcam Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.5.4 Abcam Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Abcam Recent Developments and Future Plans
2.6 Meridian Bioscience
2.6.1 Meridian Bioscience Details
2.6.2 Meridian Bioscience Major Business
2.6.3 Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.6.4 Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Meridian Bioscience Recent Developments and Future Plans
2.7 Fapon Biotech
2.7.1 Fapon Biotech Details
2.7.2 Fapon Biotech Major Business
2.7.3 Fapon Biotech Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.7.4 Fapon Biotech Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Fapon Biotech Recent Developments and Future Plans
2.8 ViroGen Corporation
2.8.1 ViroGen Corporation Details
2.8.2 ViroGen Corporation Major Business
2.8.3 ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.8.4 ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 ViroGen Corporation Recent Developments and Future Plans
2.9 Medix Biochemica
2.9.1 Medix Biochemica Details
2.9.2 Medix Biochemica Major Business
2.9.3 Medix Biochemica Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.9.4 Medix Biochemica Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Medix Biochemica Recent Developments and Future Plans
2.10 Creative Diagnostics
2.10.1 Creative Diagnostics Details
2.10.2 Creative Diagnostics Major Business
2.10.3 Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.10.4 Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Creative Diagnostics Recent Developments and Future Plans
2.11 Prospec
2.11.1 Prospec Details
2.11.2 Prospec Major Business
2.11.3 Prospec Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.11.4 Prospec Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Prospec Recent Developments and Future Plans
2.12 Cusabio
2.12.1 Cusabio Details
2.12.2 Cusabio Major Business
2.12.3 Cusabio Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.12.4 Cusabio Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Cusabio Recent Developments and Future Plans
2.13 Abbexa
2.13.1 Abbexa Details
2.13.2 Abbexa Major Business
2.13.3 Abbexa Toxoplasma Gondii Recombinant Antigen Product and Solutions
2.13.4 Abbexa Toxoplasma Gondii Recombinant Antigen Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Abbexa Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Toxoplasma Gondii Recombinant Antigen Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Toxoplasma Gondii Recombinant Antigen by Company Revenue
3.2.2 Top 3 Toxoplasma Gondii Recombinant Antigen Players Market Share in 2025
3.2.3 Top 6 Toxoplasma Gondii Recombinant Antigen Players Market Share in 2025
3.3 Toxoplasma Gondii Recombinant Antigen Market: Overall Company Footprint Analysis
3.3.1 Toxoplasma Gondii Recombinant Antigen Market: Region Footprint
3.3.2 Toxoplasma Gondii Recombinant Antigen Market: Company Product Type Footprint
3.3.3 Toxoplasma Gondii Recombinant Antigen Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Toxoplasma Gondii Recombinant Antigen Consumption Value and Market Share by Type (2021-2026)
4.2 Global Toxoplasma Gondii Recombinant Antigen Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2026)
5.2 Global Toxoplasma Gondii Recombinant Antigen Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2032)
6.2 North America Toxoplasma Gondii Recombinant Antigen Market Size by Application (2021-2032)
6.3 North America Toxoplasma Gondii Recombinant Antigen Market Size by Country
6.3.1 North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2032)
6.3.2 United States Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
6.3.3 Canada Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
6.3.4 Mexico Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2032)
7.2 Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2032)
7.3 Europe Toxoplasma Gondii Recombinant Antigen Market Size by Country
7.3.1 Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2032)
7.3.2 Germany Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
7.3.3 France Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
7.3.5 Russia Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
7.3.6 Italy Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Toxoplasma Gondii Recombinant Antigen Market Size by Region
8.3.1 Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Region (2021-2032)
8.3.2 China Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8.3.3 Japan Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8.3.4 South Korea Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8.3.5 India Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
8.3.7 Australia Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2032)
9.2 South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2032)
9.3 South America Toxoplasma Gondii Recombinant Antigen Market Size by Country
9.3.1 South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2032)
9.3.2 Brazil Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
9.3.3 Argentina Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market Size by Country
10.3.1 Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2032)
10.3.2 Turkey Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
10.3.4 UAE Toxoplasma Gondii Recombinant Antigen Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Toxoplasma Gondii Recombinant Antigen Market Drivers
11.2 Toxoplasma Gondii Recombinant Antigen Market Restraints
11.3 Toxoplasma Gondii Recombinant Antigen Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Toxoplasma Gondii Recombinant Antigen Industry Chain
12.2 Toxoplasma Gondii Recombinant Antigen Upstream Analysis
12.3 Toxoplasma Gondii Recombinant Antigen Midstream Analysis
12.4 Toxoplasma Gondii Recombinant Antigen Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Rekom Biotech Company Information, Head Office, and Major Competitors
Table 6. Rekom Biotech Major Business
Table 7. Rekom Biotech Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 8. Rekom Biotech Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Rekom Biotech Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 13. Roche Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Roche Recent Developments and Future Plans
Table 15. Thermal Fisher Company Information, Head Office, and Major Competitors
Table 16. Thermal Fisher Major Business
Table 17. Thermal Fisher Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 18. Thermal Fisher Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Bio-Rad Company Information, Head Office, and Major Competitors
Table 20. Bio-Rad Major Business
Table 21. Bio-Rad Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 22. Bio-Rad Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Bio-Rad Recent Developments and Future Plans
Table 24. Abcam Company Information, Head Office, and Major Competitors
Table 25. Abcam Major Business
Table 26. Abcam Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 27. Abcam Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Abcam Recent Developments and Future Plans
Table 29. Meridian Bioscience Company Information, Head Office, and Major Competitors
Table 30. Meridian Bioscience Major Business
Table 31. Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 32. Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Meridian Bioscience Recent Developments and Future Plans
Table 34. Fapon Biotech Company Information, Head Office, and Major Competitors
Table 35. Fapon Biotech Major Business
Table 36. Fapon Biotech Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 37. Fapon Biotech Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Fapon Biotech Recent Developments and Future Plans
Table 39. ViroGen Corporation Company Information, Head Office, and Major Competitors
Table 40. ViroGen Corporation Major Business
Table 41. ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 42. ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. ViroGen Corporation Recent Developments and Future Plans
Table 44. Medix Biochemica Company Information, Head Office, and Major Competitors
Table 45. Medix Biochemica Major Business
Table 46. Medix Biochemica Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 47. Medix Biochemica Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Medix Biochemica Recent Developments and Future Plans
Table 49. Creative Diagnostics Company Information, Head Office, and Major Competitors
Table 50. Creative Diagnostics Major Business
Table 51. Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 52. Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Creative Diagnostics Recent Developments and Future Plans
Table 54. Prospec Company Information, Head Office, and Major Competitors
Table 55. Prospec Major Business
Table 56. Prospec Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 57. Prospec Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Prospec Recent Developments and Future Plans
Table 59. Cusabio Company Information, Head Office, and Major Competitors
Table 60. Cusabio Major Business
Table 61. Cusabio Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 62. Cusabio Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Cusabio Recent Developments and Future Plans
Table 64. Abbexa Company Information, Head Office, and Major Competitors
Table 65. Abbexa Major Business
Table 66. Abbexa Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 67. Abbexa Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Abbexa Recent Developments and Future Plans
Table 69. Global Toxoplasma Gondii Recombinant Antigen Revenue (USD Million) by Players (2021-2026)
Table 70. Global Toxoplasma Gondii Recombinant Antigen Revenue Share by Players (2021-2026)
Table 71. Breakdown of Toxoplasma Gondii Recombinant Antigen by Company Type (Tier 1, Tier 2, and Tier 3)
Table 72. Market Position of Players in Toxoplasma Gondii Recombinant Antigen, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 73. Head Office of Key Toxoplasma Gondii Recombinant Antigen Players
Table 74. Toxoplasma Gondii Recombinant Antigen Market: Company Product Type Footprint
Table 75. Toxoplasma Gondii Recombinant Antigen Market: Company Product Application Footprint
Table 76. Toxoplasma Gondii Recombinant Antigen New Market Entrants and Barriers to Market Entry
Table 77. Toxoplasma Gondii Recombinant Antigen Mergers, Acquisition, Agreements, and Collaborations
Table 78. Global Toxoplasma Gondii Recombinant Antigen Consumption Value (USD Million) by Type (2021-2026)
Table 79. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Share by Type (2021-2026)
Table 80. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Forecast by Type (2027-2032)
Table 81. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026)
Table 82. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Forecast by Application (2027-2032)
Table 83. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2026) & (USD Million)
Table 84. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2027-2032) & (USD Million)
Table 85. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026) & (USD Million)
Table 86. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2027-2032) & (USD Million)
Table 87. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2026) & (USD Million)
Table 88. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2026) & (USD Million)
Table 90. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2027-2032) & (USD Million)
Table 91. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026) & (USD Million)
Table 92. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2027-2032) & (USD Million)
Table 93. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2026) & (USD Million)
Table 94. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2027-2032) & (USD Million)
Table 95. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2026) & (USD Million)
Table 96. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2027-2032) & (USD Million)
Table 97. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026) & (USD Million)
Table 98. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2027-2032) & (USD Million)
Table 99. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Region (2021-2026) & (USD Million)
Table 100. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Region (2027-2032) & (USD Million)
Table 101. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2026) & (USD Million)
Table 102. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2027-2032) & (USD Million)
Table 103. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026) & (USD Million)
Table 104. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2027-2032) & (USD Million)
Table 105. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2026) & (USD Million)
Table 106. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2027-2032) & (USD Million)
Table 107. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2026) & (USD Million)
Table 108. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2027-2032) & (USD Million)
Table 109. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Global Key Players of Toxoplasma Gondii Recombinant Antigen Upstream (Raw Materials)
Table 114. Global Toxoplasma Gondii Recombinant Antigen Typical Customers
Table 1. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Rekom Biotech Company Information, Head Office, and Major Competitors
Table 6. Rekom Biotech Major Business
Table 7. Rekom Biotech Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 8. Rekom Biotech Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Rekom Biotech Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 13. Roche Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Roche Recent Developments and Future Plans
Table 15. Thermal Fisher Company Information, Head Office, and Major Competitors
Table 16. Thermal Fisher Major Business
Table 17. Thermal Fisher Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 18. Thermal Fisher Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Bio-Rad Company Information, Head Office, and Major Competitors
Table 20. Bio-Rad Major Business
Table 21. Bio-Rad Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 22. Bio-Rad Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Bio-Rad Recent Developments and Future Plans
Table 24. Abcam Company Information, Head Office, and Major Competitors
Table 25. Abcam Major Business
Table 26. Abcam Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 27. Abcam Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Abcam Recent Developments and Future Plans
Table 29. Meridian Bioscience Company Information, Head Office, and Major Competitors
Table 30. Meridian Bioscience Major Business
Table 31. Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 32. Meridian Bioscience Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Meridian Bioscience Recent Developments and Future Plans
Table 34. Fapon Biotech Company Information, Head Office, and Major Competitors
Table 35. Fapon Biotech Major Business
Table 36. Fapon Biotech Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 37. Fapon Biotech Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Fapon Biotech Recent Developments and Future Plans
Table 39. ViroGen Corporation Company Information, Head Office, and Major Competitors
Table 40. ViroGen Corporation Major Business
Table 41. ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 42. ViroGen Corporation Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. ViroGen Corporation Recent Developments and Future Plans
Table 44. Medix Biochemica Company Information, Head Office, and Major Competitors
Table 45. Medix Biochemica Major Business
Table 46. Medix Biochemica Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 47. Medix Biochemica Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Medix Biochemica Recent Developments and Future Plans
Table 49. Creative Diagnostics Company Information, Head Office, and Major Competitors
Table 50. Creative Diagnostics Major Business
Table 51. Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 52. Creative Diagnostics Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Creative Diagnostics Recent Developments and Future Plans
Table 54. Prospec Company Information, Head Office, and Major Competitors
Table 55. Prospec Major Business
Table 56. Prospec Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 57. Prospec Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Prospec Recent Developments and Future Plans
Table 59. Cusabio Company Information, Head Office, and Major Competitors
Table 60. Cusabio Major Business
Table 61. Cusabio Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 62. Cusabio Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Cusabio Recent Developments and Future Plans
Table 64. Abbexa Company Information, Head Office, and Major Competitors
Table 65. Abbexa Major Business
Table 66. Abbexa Toxoplasma Gondii Recombinant Antigen Product and Solutions
Table 67. Abbexa Toxoplasma Gondii Recombinant Antigen Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Abbexa Recent Developments and Future Plans
Table 69. Global Toxoplasma Gondii Recombinant Antigen Revenue (USD Million) by Players (2021-2026)
Table 70. Global Toxoplasma Gondii Recombinant Antigen Revenue Share by Players (2021-2026)
Table 71. Breakdown of Toxoplasma Gondii Recombinant Antigen by Company Type (Tier 1, Tier 2, and Tier 3)
Table 72. Market Position of Players in Toxoplasma Gondii Recombinant Antigen, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 73. Head Office of Key Toxoplasma Gondii Recombinant Antigen Players
Table 74. Toxoplasma Gondii Recombinant Antigen Market: Company Product Type Footprint
Table 75. Toxoplasma Gondii Recombinant Antigen Market: Company Product Application Footprint
Table 76. Toxoplasma Gondii Recombinant Antigen New Market Entrants and Barriers to Market Entry
Table 77. Toxoplasma Gondii Recombinant Antigen Mergers, Acquisition, Agreements, and Collaborations
Table 78. Global Toxoplasma Gondii Recombinant Antigen Consumption Value (USD Million) by Type (2021-2026)
Table 79. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Share by Type (2021-2026)
Table 80. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Forecast by Type (2027-2032)
Table 81. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026)
Table 82. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Forecast by Application (2027-2032)
Table 83. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2026) & (USD Million)
Table 84. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2027-2032) & (USD Million)
Table 85. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026) & (USD Million)
Table 86. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2027-2032) & (USD Million)
Table 87. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2026) & (USD Million)
Table 88. North America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2026) & (USD Million)
Table 90. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2027-2032) & (USD Million)
Table 91. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026) & (USD Million)
Table 92. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2027-2032) & (USD Million)
Table 93. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2026) & (USD Million)
Table 94. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2027-2032) & (USD Million)
Table 95. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2026) & (USD Million)
Table 96. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2027-2032) & (USD Million)
Table 97. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026) & (USD Million)
Table 98. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2027-2032) & (USD Million)
Table 99. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Region (2021-2026) & (USD Million)
Table 100. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value by Region (2027-2032) & (USD Million)
Table 101. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2026) & (USD Million)
Table 102. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2027-2032) & (USD Million)
Table 103. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026) & (USD Million)
Table 104. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2027-2032) & (USD Million)
Table 105. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2026) & (USD Million)
Table 106. South America Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2027-2032) & (USD Million)
Table 107. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2021-2026) & (USD Million)
Table 108. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Type (2027-2032) & (USD Million)
Table 109. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Global Key Players of Toxoplasma Gondii Recombinant Antigen Upstream (Raw Materials)
Table 114. Global Toxoplasma Gondii Recombinant Antigen Typical Customers
LIST OF FIGURES
Figure 1. Toxoplasma Gondii Recombinant Antigen Picture
Figure 2. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type in 2025
Figure 4. Full-Length Antigen
Figure 5. Truncated Antigen
Figure 6. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application in 2025
Figure 8. In Vitro Diagnostics Picture
Figure 9. Vaccine Development Picture
Figure 10. Others Picture
Figure 11. Global Toxoplasma Gondii Recombinant Antigen Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Toxoplasma Gondii Recombinant Antigen Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Market Toxoplasma Gondii Recombinant Antigen Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 14. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Region (2021-2032)
Figure 15. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Region in 2025
Figure 16. North America Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 17. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 18. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 19. South America Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 20. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Toxoplasma Gondii Recombinant Antigen Revenue Share by Players in 2025
Figure 23. Toxoplasma Gondii Recombinant Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 24. Market Share of Toxoplasma Gondii Recombinant Antigen by Player Revenue in 2025
Figure 25. Top 3 Toxoplasma Gondii Recombinant Antigen Players Market Share in 2025
Figure 26. Top 6 Toxoplasma Gondii Recombinant Antigen Players Market Share in 2025
Figure 27. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Share by Type (2021-2026)
Figure 28. Global Toxoplasma Gondii Recombinant Antigen Market Share Forecast by Type (2027-2032)
Figure 29. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Share by Application (2021-2026)
Figure 30. Global Toxoplasma Gondii Recombinant Antigen Market Share Forecast by Application (2027-2032)
Figure 31. North America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type (2021-2032)
Figure 32. North America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2032)
Figure 33. North America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Country (2021-2032)
Figure 34. United States Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 35. Canada Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 36. Mexico Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type (2021-2032)
Figure 38. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2032)
Figure 39. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Country (2021-2032)
Figure 40. Germany Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 41. France Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 42. United Kingdom Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 43. Russia Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 44. Italy Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 45. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type (2021-2032)
Figure 46. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2032)
Figure 47. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Region (2021-2032)
Figure 48. China Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 49. Japan Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 50. South Korea Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 51. India Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 52. Southeast Asia Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 53. Australia Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type (2021-2032)
Figure 55. South America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2032)
Figure 56. South America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Country (2021-2032)
Figure 57. Brazil Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 58. Argentina Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 59. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type (2021-2032)
Figure 60. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2032)
Figure 61. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Country (2021-2032)
Figure 62. Turkey Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 63. Saudi Arabia Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 64. UAE Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 65. Toxoplasma Gondii Recombinant Antigen Market Drivers
Figure 66. Toxoplasma Gondii Recombinant Antigen Market Restraints
Figure 67. Toxoplasma Gondii Recombinant Antigen Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Toxoplasma Gondii Recombinant Antigen Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Toxoplasma Gondii Recombinant Antigen Picture
Figure 2. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type in 2025
Figure 4. Full-Length Antigen
Figure 5. Truncated Antigen
Figure 6. Global Toxoplasma Gondii Recombinant Antigen Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application in 2025
Figure 8. In Vitro Diagnostics Picture
Figure 9. Vaccine Development Picture
Figure 10. Others Picture
Figure 11. Global Toxoplasma Gondii Recombinant Antigen Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Toxoplasma Gondii Recombinant Antigen Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Market Toxoplasma Gondii Recombinant Antigen Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 14. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Region (2021-2032)
Figure 15. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Region in 2025
Figure 16. North America Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 17. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 18. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 19. South America Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 20. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Toxoplasma Gondii Recombinant Antigen Revenue Share by Players in 2025
Figure 23. Toxoplasma Gondii Recombinant Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 24. Market Share of Toxoplasma Gondii Recombinant Antigen by Player Revenue in 2025
Figure 25. Top 3 Toxoplasma Gondii Recombinant Antigen Players Market Share in 2025
Figure 26. Top 6 Toxoplasma Gondii Recombinant Antigen Players Market Share in 2025
Figure 27. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Share by Type (2021-2026)
Figure 28. Global Toxoplasma Gondii Recombinant Antigen Market Share Forecast by Type (2027-2032)
Figure 29. Global Toxoplasma Gondii Recombinant Antigen Consumption Value Share by Application (2021-2026)
Figure 30. Global Toxoplasma Gondii Recombinant Antigen Market Share Forecast by Application (2027-2032)
Figure 31. North America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type (2021-2032)
Figure 32. North America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2032)
Figure 33. North America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Country (2021-2032)
Figure 34. United States Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 35. Canada Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 36. Mexico Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type (2021-2032)
Figure 38. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2032)
Figure 39. Europe Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Country (2021-2032)
Figure 40. Germany Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 41. France Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 42. United Kingdom Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 43. Russia Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 44. Italy Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 45. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type (2021-2032)
Figure 46. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2032)
Figure 47. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Region (2021-2032)
Figure 48. China Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 49. Japan Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 50. South Korea Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 51. India Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 52. Southeast Asia Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 53. Australia Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type (2021-2032)
Figure 55. South America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2032)
Figure 56. South America Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Country (2021-2032)
Figure 57. Brazil Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 58. Argentina Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 59. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Type (2021-2032)
Figure 60. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Application (2021-2032)
Figure 61. Middle East & Africa Toxoplasma Gondii Recombinant Antigen Consumption Value Market Share by Country (2021-2032)
Figure 62. Turkey Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 63. Saudi Arabia Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 64. UAE Toxoplasma Gondii Recombinant Antigen Consumption Value (2021-2032) & (USD Million)
Figure 65. Toxoplasma Gondii Recombinant Antigen Market Drivers
Figure 66. Toxoplasma Gondii Recombinant Antigen Market Restraints
Figure 67. Toxoplasma Gondii Recombinant Antigen Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Toxoplasma Gondii Recombinant Antigen Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
